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1ABSTRACT
Safety and feasibility of simultaneous endoscopic submucosal dissection 
for multiple gastric neoplasias
Dong Hoo Joh
Department of Medicine
The Graduate School, Yonsei University
(Directed by Professor Sang Kil Lee)
Background: Synchronous gastric neoplasms are not infrequently detected, 
thus endoscopic submucosal dissection (ESD) for multiple early gastric 
neoplasia is occasionally considered. However, there have been few 
investigations of the safety and feasibility of simultaneous ESD for multiple 
gastric lesions. This study aims to evaluate the safety and feasibility of 
simultaneous ESD for multiple gastric neoplasia.
Methods : A total of 1,823 patients who underwent ESD for 1,929 gastric 
adenomas or early gastric cancers were retrospectively reviewed in this study. 
Two hundred gastric adenomas or early gastric cancers among 94 patients were 
treated by ESD simultaneously (multiple group) and 1,729 patients were treated 
with ESD for a single lesion (single group). 
Results: En bloc resection (P = 0.060), complete resection (P = 0.362) and 
curative resection (P = 0.108) rates did not differ between the two groups. Rates 
2of adverse events including bleeding (P = 0.317), perforation (P = 0.316) and 
aspiration pneumonia (P = 0.563) were not higher in the multiple group. 
Long-term follow up showed more frequent local recurrence (P < 0.001), 
synchronous neoplasia (P = 0.041) and metachronous neoplasia (P < 0.001) per 
patient in the multiple group; however, local recurrence per lesion did not differ 
between the two groups (P = 0.103). 
Conclusions: Simultaneous ESD for multiple synchronous gastric neoplasms is 
safe and feasible compared to single ESD. However, thorough examination for 
local recurrence and synchronous and metachronous neoplasia is required.
--------------------------------------------------------------------------------------
Key words: Endoscopic submucosal dissection; multiple gastric neoplasms; 
outcomes
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I. INTRODUCTION
The detection and diagnosis of early gastric cancer has increased due to 
advances in endoscopic examination and endoscopic screening. Endoscopic 
resection as a minimally-invasive therapy has been widely accepted in Asian 
countries, including Korea and Japan, for cases of gastric neoplasia that are 
confined to the mucosa and have little evidence of lymph node metastasis1-3. In 
particular, endoscopic submucosal dissection (ESD) is widely used because it 
allows for a single slice resection of gastric lesions, regardless of tumor size4,5. 
Two or more malignant foci in the stomach are often diagnosed during 
endoscopy and are known as synchronous multifocal gastric cancer. The 
incidence of concurrent multiple gastric carcinomas has been reported to range 
from 4.8 to 23.8% in studies of excised stomach specimens6-9. The incidence of 
synchronous multiple gastric carcinomas after endoscopic resection is reported
4from 1.0 to 5.6%10,11. Epidemiologically, the risk factors known for multiple 
gastric carcinomas are old age and male sex12. Histologically, multiple gastric 
carcinomas often arise in the gastric mucosa with severe intestinal 
metaplasia12-14.
Recent studies have shown that multiple synchronous EGCs have 
clinicopathologic features with respect to tumor size, depth of invasion, 
lymphovascular invasion, and incidence of lymph node metastasis similar to 
those of solitary EGCs15,16. Therefore, endoscopic treatment could be feasible 
when major and minor lesions are predicted to represent mucosal cancer 
without lymphovascular invasion. 
However, ESD is a time-consuming procedure that requires great endoscopic 
skill4,17. Simultaneous ESD for multiple gastric neoplasms would increase 
procedure time and the amount of resected mucosa. Considering the reports 
describing large size and long procedure time as risk factors for adverse events,
simultaneous ESD may increase the risk of complications and unfavorable 
outcomes18,19. On the other hand, separate procedures with a time interval 
between each gastric lesion would result in a longer period of hospitalization 
and increase medical expense.
To the best of our knowledge, there have been few studies evaluating adverse 
events, feasibility or outcomes related to ESD for multifocal gastric neoplasms.
A recent study performed in Japan demonstrated comparable procedural 
outcomes and complication rates of simultaneous ESD to those of single ESD. 
5However, the literature reviewed relatively small number of patients, and did 
not evaluate long term outcomes20. Our study aimed to evaluate the safety, 
feasibility and outcomes of simultaneous ESD for multiple synchronous gastric 
neoplasia and compare it to that of ESD for solitary gastric lesion.
6II. MATERIALS AND METHODS
1. Patients
Patients with gastric neoplasia who underwent ESD were prospectively 
followed at a single tertiary teaching hospital in Seoul, Korea from January 
2008 to December 2011. Clinical data included patient demographics, 
pathologic data of gastric neoplasms, results of endoscopic resection, and 
procedure-related adverse events including bleeding and perforation. A total of 
94 patients underwent simultaneous ESD for a total of 200 synchronous EGCs 
or gastric adenomas. They were compared to 1,729 patients who underwent 
ESD for single gastric neoplasm. Gastric neoplasms included in the study were 
selected based on the expanded criteria proposed by Gotoda et al.3. The patients 
in the multiple group were treated by ESD under a single anesthesia on a single 
day. Patients who had prior gastric resection were excluded. The institutional 
review board of the hospital approved this study. (Approval number:
4-2013-0382)
2. Study definitions
The macroscopic type and location of EGC were classified according to the 
Japanese Gastric Cancer Association classification system21. En bloc resection 
was defined as resection in a single piece as opposed to resection of multiple 
7pieces. Complete resection was defined as tumor-free lateral and vertical 
margins on pathologic examination. Curative resection was defined as en bloc
and complete resection without submucosal invasion deeper than 500 μm from 
the muscularis mucosae, lymphatic invasion and vascular involvement. The 
main lesion was defined as being histologically more advanced, and larger, if 
the histology was the same. The accessory lesion was defined as histologically 
less advanced, and smaller, if histology was the same. The diameter of the 
lesion was defined as the longest diameter of the neoplasm measured in the 
resected specimen on pathologic examination. Procedure time was defined as 
the time from marking of mucosa to complete removal, including the time 
required for hemostasis. Bleeding was defined as (A) intraoperative bleeding 
that required blood transfusion, (B) clinical symptoms such as melena or 
hematemesis, or (C) a decrease in hemoglobin level greater than 2 g/dL 
following procedure. A diagnosis of perforation required direct endoscopic 
visualization of mesenteric fat or radiographic evidence of free air. Pneumonia 
was defined as new or progressive consolidation with one of the following 
newly developed criteria: (A) cough, (B) purulent sputum or change in 
character of sputum, or (C) rales or dullness to percussion on physical 
examination of the chest22. Parenteral administration of non-steroidal 
anti-inflammatory drugs or opioid analgesics was analyzed as the number of 
pain killer injections. Complete blood cell counts measured at the day of 
hospitalization and the day after ESD were retrospectively reviewed
83. ESD methods
Endoscopic procedure was done with single channel endoscope with jet 
function available (GIF Q260J or GIF-H260Z, Olympus Optical Co. Ltd., 
Tokyo, Japan). After endoscopic evaluation of the gastric lesions with 
indigocarmine stain, the surrounding lesion was marked by electrocautery (ICC 
200; ERBE, Tübingen, Germany) using an argon plasma coagulation probe or a 
needle knife (KD-10Q-1-A, Olympus Optical Co. Ltd., Tokyo, Japan). Saline 
mixed with epinephrine (0.01mg/mL) and 0.8% indigo carmine was injected 
into the submucosa to lift the lesion. A circumferential incision (precut) was 
made along the outer border of the lesion using a needle knife and an
insulated-tipped knife (IT knife, KD-610L, Olympus Optical Co. Ltd., Tokyo, 
Japan). The submucosal layer was then dissected with the IT knife until 
complete removal was achieved. Endoscopic hemostasis was performed with 
hemoclips or hemostatic forceps for bleeding or exposed vessels. For multiple 
synchronous lesions, marking was performed for all lesions initially. After 
complete dissection and hemostasis of the first lesion, an epinephrine mixture 
was injected, and a precut was made subsequently for the residual neoplasms. 
4. Follow-up
For EGCs, EGD was scheduled at 3, 6, 12, 18, 24 months after ESD to check 
9for local or metachronous lesions. After 24 months, EGD was performed 
annually. For adenomas, EGD was performed at 3, 12 months after ESD and 
annually thereafter.
Recurrent neoplasia detected at the curatively resected site was regarded as 
local recurrence. A second neoplasm detected at the gastric site other than the 
primary resection area within 12 months after endoscopic resection was defined 
as synchronous. A second neoplasm found at sites other than the primary 
resection area at 12 months or later was defined as metachronous.
5. Statistical analysis
For statistical analysis, χ2 test, Fisher’s exact test and t test were used. The
Kaplan-Meier method and a log-rank test were used for survival analysis of 
long-term outcomes. A P-value <0.05 was regarded as a significant difference 
for group comparisons. Statistical analysis was performed using SPSS 18.0 for 
Windows (IBM., Chicago, IL, USA).         
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II. RESULTS
1. Baseline characteristics of patients
A total of 1,823 patients who had undergone endoscopic resection for 1,929
gastric adenomas or early gastric cancers were enrolled in this study. 
Ninety-four patients had two or more gastric lesions. The rate of simultaneous 
ESD for synchronous gastric neoplasia was 5.16% (94 out of 1,823). The 
baseline characteristics of patients who underwent endoscopic resection are 
shown in Table 1. The mean age was greater in patients with multiple lesions 
(67.03 ± 7.35 vs. 63.28 ± 9.44, P < 0.001). A history of cigarette smoking was 
more common (61.7% vs. 47.8%, P = 0.009), and underlying comorbid disease, 
including cardiovascular disease, renal disease, diabetes, and chronic viral 
hepatitis, were more frequent in patients with multiple lesions (62.8% vs. 48.0%, 
P = 0.005). Other baseline characteristics of the patients did not differ between 
the two groups.
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Table 1. Baseline characteristics of patients 
Single group Multiple group P-value
Number of patients, n 1,729 94
Sex, male, n (%) 1,217 (70.4%) 68 (72.3%) 0.686
Age, mean ± SD 63.28 ± 9.44 67.03 ± 7.35 < 0.001
Cigarette smoking, n (%) 827 (47.8%) 58 (61.7%) 0.009
Alcohol use, n (%) 917(53.0%) 55 (58.5%) 0.3
NSAID use, n (%) 196 (11.3%) 9 (9.6%) 0.599
Comorbiditiesa, n (%) 830 (48%) 59 (62.8%) 0.005
H.pylori infectionb, n (%) 461/1,057 (43.6%) 17/52 (32.7%) 0.121
a Comorbidities include cardiovascular disease, renal disease, diabetes, and chronic 
viral hepatitis.
b H.pylori infection was investigated in a limited number of patients. H.pylori
infection test methods: urea breath test, rapid urease test and H-E stain.
SD, standard deviation
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2. Comparison of clinicopathologic characteristics of gastric neoplasms
In the multiple group, 12 patients had triple lesions and the remaining 82 had 
double lesions. Morphologic and pathologic characteristics of the main lesions, 
which were histologically more advanced or larger when histology was the 
same, were compared to those of the solitary lesions. The mean diameter of the 
main lesion of the multiple group was significantly longer than that of the single 
group (15.24 ± 9.89mm vs. 12.90 ± 9.30mm, P = 0.020). Histology, shape and 
location were comparable between the two groups (Table 2). When the main
lesion was compared to the accessory lesions of the multiple group, shape and 
location did not differ (Table 3).
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Table 2. Characteristics of gastric neoplasms
Single group 
(N = 1,729)
Main lesion of 
multiple group 
(N = 94)
P-value
Histology 0.524
Grade of adenoma
LGD, n (%) 600 (34.7%) 32 (34.0%)
HGD, n (%) 212 (12.3%) 7 (7.4%)
Differentiation of carcinomaa
Differentiated (WD+MD), n (%) 813 (47.0%) 49 (52.1%)
Undifferentiated (PD+SRC), n (%) 104 (6.0%) 6 (6.4%)
Shape 0.217
Elevated, n (%) 1,362 (78.8%) 81 (86.2%)
Flat, n (%) 122 (7.1%) 5 (5.3%)
Depressed, n (%) 245 (14.2%) 8 (8.5%)
Location 0.161
Upper third, n (%) 130 (7.5%) 7 (7.4%)
Middle third, n (%) 360 (20.8%) 12 (12.8%)
Lower third, n (%) 1,239 (71.7%) 75 (79.8%)
Diameter of lesions, mean ± SD, mm 12.90 ± 9.30 15.24 ± 9.89 0.020
a Differentiated carcinoma includes well-differentiated carcinoma (WD) and 
moderately differentiated carcinoma (MD); undifferentiated carcinoma includes 
poorly-differentiated carcinoma (PD) and signet ring cell carcinoma (SRC)
LGD, low-grade dysplasia; HGD, high-grade dysplasia; SD, standard deviation
14
Table 3. Comparison of main and accessory lesions of the multiple group
Main lesion 
(N = 94) 
Accessory lesions
(N = 106) 
P-value
Histology <0.001
Grade of adenoma
LGD, n (%) 32 (34.0%) 72 (67.9%)
HGD, n (%) 7 (7.4%) 17 (16.0%)
Differentiation of carcinomaa
Differentiated (WD+MD), n (%) 49 (52.1%) 17 (16.0%)
Undifferentiated (PD+SRC), n (%) 6 (6.4%) 0 (0%)
Shape 0.768
Elevated, n (%) 81 (86.2%) 89 (84.0%)
Flat, n (%) 4 (4.3%) 7 (6.6%)
Depressed, n (%) 9 (9.6%) 10 (9.4%)
Location 0.730
Upper third, n (%) 7 (7.4%) 11 (10.4%)
Middle third, n (%) 21 (22.3%) 21 (19.8%)
Lower third, n (%) 66 (70.2%) 74 (52.9%)
Diameter of lesions, mean ± SD, mm 15.24 ± 9.9 9.85 ± 5.80 <0.001
a Differentiated carcinoma includes well-differentiated carcinoma (WD) and 
moderately differentiated carcinoma (MD), undifferentiated carcinoma includes 
poorly differentiated carcinoma (PD) and signet ring cell carcinoma (SRC)
LGD, low-grade dysplasia; HGD, high-grade dysplasia; SD, standard deviation
15
3. Comparison of complications and morbidities
Table 4 shows a comparison of the procedure time, adverse events and 
variables related to morbidity in each group. The mean procedure time was 
longer in the multiple group (94.99 ± 48.96 min vs. 57.91 ± 42.73 min, P < 
0.001), but adverse events including bleeding, perforation and aspiration 
pneumonia did not differ between the two groups. The mean number of hospital 
days and pain killer injections were not significantly different between the two 
groups. Also, the decrement of serum hemoglobin level was not significantly 
different between the two groups; however, the increment of white blood cell 
(WBC) count was larger in the multiple ESD group (4,335 ± 2,694/uL vs. 3,725 
± 2,610/uL, P = 0.034).
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Table 4. Complications and morbidity related to endoscopic submucosal dissection
Single group
(N = 1,729)
Multiple group
(N = 94)
P-value
Procedure time, mean ± SD, min 57.91 ± 42.73 94.99 ± 48.96 < 0.001
Adverse events
Bleeding, n (%) 82 (4.7%) 2 (2.1%) 0.317
Perforation, n (%) 45 (2.6%) 4 (4.3%) 0.316
Aspiration pneumonia, n (%) 59 (3.4%) 4 (4.3%) 0.563
Δ WBC count, mean ± SD, /uL 3,725 ± 2,610 4,335 ± 2,694 0.034
Δ Hb, mean ± SD, g/dL 0.41 ± 0.94 0.44 ± 0.91 0.748
Hospital daysa, mean ± SD 4.24 ± 3.87 5.85 ± 15.42 0.136
Pain killers usedb, mean ± SD 0.99 ± 2.13 1.26 ± 1.45 0.094
a Statistical significance was determined by Mann-Whitney U-test since the parameter 
showed non-normal distribution
b Number of parenteral administration of NSAID or opioid analgesics for pain control 
during hospitalization after the procedure 
Δ refers to elevation of the serologic value from baseline to the value tested at the day 
after the endoscopic procedure 
SD, stand deviation; WBC, white blood cell; Hb, hemoglobin
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4. Procedural outcomes and long-term outcomes
As shown in Table 5, the procedural outcome including en bloc resection, 
complete resection and curative resection did not differ between the two groups. 
Patients who were curatively resected and who had a follow-up period longer 
than one year were analyzed for long-term outcome. In total, 1,184 patients for 
single group and 54 patients for multiple group were analyzed, and the median 
follow-up periods were 27 months (interquartile range (IQR) 18.3 to 36.3 
months) and 19 months (IQR 13.0 to 24.2 months), respectively. The 
cumulative local recurrence (P < 0.001), cumulative incidence of synchronous 
neoplasia (P = 0.041) and metachronous neoplasia (P < 0.001) were higher in 
the multiple group. Among five cases of local recurrence in the multiple 
neoplasms, four occurred at the main lesion. However, when the cumulative 
incidence of local recurrence was considered per resected lesion, not per patient, 
there was no difference in the two groups (P = 0.103) (Figure 1).
Figure 2 shows that the estimated disease-free survival was significantly 
longer in the single group compared to the multiple group (45.41 ± 0.32 months 
vs. 38.90 ± 2.45 months, P < 0.001).
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Table 5. Procedural outcomes
Single group
(N = 1729)
Multiple group
(N = 200)
P-value
En bloc resection, n (%) 1,608 (93.0%) 193 (96.5%) 0.060
Complete resection, n (%) 1,594 (92.2%) 188 (94.0%) 0.362
Curative resection, n (%) 1,465 (84.7%) 178 (89.0%) 0.108
19
Figure 1. Kaplan Meier plot for long-term outcomes 
(a) Cumulative incidence of local recurrence per patient and (b) per resected lesion. (c) 
Cumulative incidence of synchronous neoplasia and (d) metachronous neoplasia
Curatively resected patients who had a follow-up period longer than one year were 
analyzed for long-term outcomes. 1,184 patients from the single ESD group and 54 
patients from the multiple ESD group were analyzed, and the median follow-up period 
was 27 months (IQR of 18.3 to 36.3 months) and 19 months (IQR of 13.0 to 24.2 
months), respectively. 
ESD, endoscopic submucosal dissection; IQR, interquartile range
20
Figure 2. Comparison of disease-free survival between single ESD and multiple ESD
group
ESD, endoscopic submucosal dissection
21
IV. DISCUSSION
Our study is the largest study to demonstrate the safety and feasibility of 
simultaneous ESD for multiple lesions as compared to ESD for a single lesion. 
A previous study evaluating safety and efficacy of simultaneous ESD for 
synchronous double EGCs only included double lesions (not triple), a relatively 
small number of patients and there was no analysis of long-term outcomes20. 
In this study, comparison of the single group and the multiple group revealed 
no significant difference in adverse events including bleeding, perforation and 
aspiration pneumonia. Also, patients in the multiple group showed neither 
longer hospitalization nor more pain killer injections. Review of the resected 
specimens showed no significant difference in the rate of en bloc resection, 
complete resection or curative resection. Our findings demonstrate that the 
technical safety and feasibility of simultaneous ESD for multiple gastric 
neoplasms is acceptable compared to ESD for a single neoplasm. On the other 
hand, metachronous recurrence after endoscopic resection in the multiple group 
was significantly higher than that in the single group.
In this present study, baseline characteristics showed that patients in the 
multiple group were older and more likely to have comorbidities than the 
patients in the single group. This corresponds to the previous studies reporting
old age as one of the risk factors for multifocality in gastric neoplasms8.
Frequent comorbidities in the multiple group may be ascribed to older age, 
since more comorbidities are generally expected in the elderly.
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As expected, the procedure time was significantly longer in the multiple group. 
However, the mean procedure time for simultaneous ESD was not twice that of 
single ESD procedures. This may be due to ease of ESD of accessory lesions 
compared to the main lesion resulting from less advanced histology and smaller 
diameter.
Longer procedure time and poor visual field due to the previously resected 
specimen or blood clots may interfere with the resection of second or third 
target lesions. Nevertheless, our data did not show evidence of frequent adverse 
events such as bleeding, perforation or aspiration pneumonia related to 
simultaneous ESD. The rate of perforation was remarkably high in the multiple 
group (4.3% vs 2.6%), but did not reach statistical significance. The majority of 
perforation events were minimal and conservatively managed (39 out of 45 
cases in the single group and all 4 cases in the multiple group). However, the 
increment of WBC count was significantly higher in the multiple ESD group. 
There were reports describing large size and long procedure time as risk factors 
for adverse events18,19. A previous study performed in our institute demonstrated 
a procedure time of more than two hours as a risk factor for aspiration 
pneumonia during ESD23. Moreover, a recent study performed in Japan 
indicated that procedure time longer than 150 minutes is an independent 
predictor of adverse events in simultaneous ESD for double EGC20. Though the 
mean procedure time did not reach two hours in our study, ESD took longer for 
the multiple group than for the single group, which may be related to minor 
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events of aspiration and pulmonary infection. Moreover, a larger amount of 
resected mucosa and mucosal injury from electrocauterization may account for 
inflammatory reactions which can lead to leukocytosis. 
The mean number of hospital days was greater in the multiple group, but the 
difference was not statistically significant. Also, patients in the multiple group 
received more parenteral pain killer injections after the procedure, but this 
difference was also not statistically significant. According to our results, it’s 
unlikely that simultaneous ESD would cause more medical expense or 
morbidity. Rather, separate performance of endoscopic procedures would 
prolong hospitalization and consequently cause more medical expenses. 
On long-term follow up, local recurrence was more frequent in the multiple 
group than the single group. However, considering the risk of recurrence per 
lesion, the risk of local recurrence may well be increased with multiple lesions. 
In fact, the cumulative incidence of local recurrence per resected lesion did not 
differ between the two groups (P = 0.103). Therefore, more thorough 
examination and biopsies of each resected site during follow up are important.
Reported overall incidence rates of metachronous gastric cancer after 
endoscopic resection range from 7.9 to 14% 24-28. As for predictive factors, 
synchronous multiplicity of the gastric cancer and patient age at the time of the 
initial endoscopic resection have been reported to significantly affect the 
incidence of metachronous lesions26. Our results, which showed a higher 
incidence of synchronous neoplasia as well as metachronous neoplasia in the 
24
multiple group, are consistent with the results from the previous report.
However, this finding was not adjusted by known risk factor of metachronous 
neoplasia such as H.pylori status and extent of atrophy due to limited available 
data29,30.  
The main limitation of this study is that it was a retrospective single-center 
study. However, the number of patients included in this study was large, and 
most of the data used for this study were collected prospectively for future 
analysis, so there was little chance of bias. Future studies with a larger number 
of cases and a longer follow-up period would be useful to verify our results. 
.
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V. CONCLUSION
Simultaneous ESD of multiple gastric neoplasms is safe, feasible and may 
reduce overall medical expense compared to multiple ESD separated by time 
intervals. However, in order to maintain optimal outcome, thorough 
examination for local recurrence, synchronous and metachronous neoplasia is 
essential.
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ABSTRACT(IN KOREAN)
다발성 위종양에 대한 동시적 내시경 점막하 박리술의 안전성
및 적합성
<지도교수 이상길>
연세대학교 대학원 의학과
조 동 후
배경: 다발성 위종양은 비교적 흔하게 발견되며 이들을
치료하기 위해 동시에 내시경 점막하 박리술을 시행하는 경우가
종종 있다. 하지만 다발성 위종양에 대한 동시적 내시경 점막하
박리술을 시행하는 것이 안전하고 적합한지에 대한 연구는 거의
없는 실정이다. 
목적: 본 연구에서는 다발성 위종양에 대한 동시적 내시경
점막하 박리술의 안정성과 적합성에 대해 조사하였다.
방법: 총 94명의 환자가 200 개의 위선종 혹은 조기위암에 대해
동시에 내시경 점막하 박리술을 시행받았으며 (다발성 병변군), 
1,729명의 환자가 단일 병변에 대해 내시경 점막하 박리술을
시행받았다 (단일 병변군). 두 환자군의 합병증, 시술 성과, 
장기적인 치료 결과에 대해 비교하였다.
결과:  완전 절제율 (P = 0.362), 일괄 절제율 (P = 0.060), 근치적
절제율 (P = 0.108) 면에서 두 군의 차이는 없었으며 출혈 (P =
0.317), 천공 (P = 0.316) 및 흡인성 폐렴 (P = 0.563) 등의 합병증
면에서도 두 군간의 유의한 차이가 없었다. 장기적인 추적관찰
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결과, 다발성 병변군에서 통계학적으로 유의하게 국소 재발 (P <
0.001), 동시성 병변 (P = 0.041) 및 이시성 병변의 (P < 0.001)
발견 빈도가 높았다. 
결론:  다발성 위종양에 대한 동시적 내시경 점막하 박리술은
안전하고 적합하다. 그러나 장기적으로 국소 재발과 동시성 및
이시성 병변에 대해 유의하여 추적해야 한다.  
----------------------------------------------------------------------------------------
핵심되는 말 : 다발성 위종양, 내시경 점막하 박리술, 결과
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